Prognostic Role of the IMPACT Scoring System in Myasthenia Gravis: A Study Based on Machine Learning and Multimodal Model Fusion

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2500099093

Enrollment

Unknown

Registered

2025-03-18

Start date

2025-03-25

Completion date

Unknown

Last updated

2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myasthenia gravis

Interventions

Myasthenia Gravis Case Group:Not applicable

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Conform to MG diagnostic criteria : Necessary conditions : typical symptoms, with fluctuating muscle weakness and morbid fatigue. Support condition a.fatigue test positive and neostigmine test positive. b. AChR antibody or other MG antibody positive. C : The amplitude of low-frequency repetitive nerve stimulation ( low-frequency RNS ) decreased by > 10 %. Add any support condition on the basis of the necessary conditions.

Exclusion criteria

Exclusion criteria: 1 .have severe complications ( such as cardiac insufficiency, severe pulmonary infection, cognitive or mental disorders, etc. ) impact assessment. 2 . Clinical evaluation of limb muscle strength reduction or eye diseases caused by other neuromuscular diseases.

Design outcomes

Primary

Measure	Time frame
If the MGFA-PIS classification reach MM or better;	—

Countries

China

Contacts

Public ContactXiaodong Liu

Shiyan Taihe Hospital

liuxiaodong@taihehospital.com+86 158 7112 2159

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026